GHGuardant Health, Inc.
$168.98+150% 1Y
$168.98
$65.4652 weeks$187.33
Is the price fair?
What GH's price assumes
Guardant Health, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 19.2× revenue.
19.2
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 19.6
EV / sales
Details›
- EV / EBIToperating margin −40%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 19.6
- Market capitalisation134.2 million shares, counted Jul 24, 2026
- $22.7B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Diagnostics & Research
Ranks #17 of 21 by RyuScore